Odyssey Therapeutics, Inc.
7.10%
3,333,516
1882782
May 7, 2026
May 15, 2026, 04:08 PM
Reporting Persons (7)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Dimension Management, L.P. | Investment Adviser | 7.10% | 3,333,516 | 0 | 3,333,516 |
| Dimension Capital II, L.P. | Partnership | 7.10% | 3,333,516 | 0 | 3,333,516 |
| Dimension Capital II GP, LLC | CO | 7.10% | 3,333,516 | 0 | 3,333,516 |
| Dimension Management GP, LLC | CO | 7.10% | 3,333,516 | 0 | 3,333,516 |
| Adam Goulburn | Individual | 7.10% | 3,333,516 | 0 | 3,333,516 |
| Zavain Dar | Individual | 7.10% | 3,333,516 | 0 | 3,333,516 |
| Nan Li | Individual | 7.10% | 3,333,516 | 0 | 3,333,516 |
Disclosure Items (7)
Common Stock, $0.0001 par value per share
Odyssey Therapeutics, Inc.
51 Sleeper Street, Boston, MA, 02210
The names of the persons filing this report (collectively, the "Reporting Persons") with respect to shares of Common Stock, par value $0.0001 per share (the "Common Stock") of Odyssey Therapeutics, Inc. (the "Issuer") are: Dimension Management, L.P. ("Dimension Management") Dimension Capital II, L.P. ("Dimension Capital II") Dimension Capital II GP, LLC ("Dimension Capital II GP") Dimension Management GP, LLC ("Dimension Management GP," and together with Dimension Management, Dimension Capital II, and Dimension Capital II GP, the "Dimension Entities") Adam Goulburn Zavain Dar Nan Li Dimension Management is the investment advisor to Dimension Capital II. Dimension Management GP is the general partner of the general partner of Dimension Management. Dimension Capital II GP is the general partner of the general partner of Dimension Capital II. Mr. Goulburn, Mr. Dar, and Mr. Li are members of each of Dimension Management GP and Dimension Capital II GP.
The address of the principal business office of each of the Reporting Persons is 632 Broadway, Suite 801, New York, NY 10012.
The principal business of the Dimension Entities is the purchase, holding, and selling of securities for investment purposes. The principal occupation of each of Mr. Goulburn, Mr. Dar, and Mr. Li is the management of the Dimension Entities and other related entities.
During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Each of Dimension Management and Dimension Capital II is a Delaware limited partnership. Each of Dimension Capital II GP and Dimension Management GP is a Delaware limited liability company. Mr. Goulburn is an Australian citizen. Each of Mr. Dar and Mr. Li is a United States citizen.
Prior to the Issuer's initial public offering (the "IPO"), Dimension Capital II acquired (i) 512,862 shares of Common Stock for an aggregate purchase price of $49,835 through the exercise of warrants held by Dimension Capital II (such number giving effect to the Issuer's 1-for-9.7170 reverse stock split effected prior to the closing of the IPO) and (ii) shares of Series D Convertible Preferred Stock (the "Preferred Stock") that automatically converted into 1,709,543 shares of Common Stock at the closing of the Issuer's IPO for an aggregate purchase price of $24,999,999. Dimension Capital II acquired 1,111,111 shares of Common Stock for an aggregate purchase price of $19,999,998 in the Issuer's IPO. The source of funds for the acquisitions of Common Stock and Preferred Stock reported on this Schedule 13D was the working capital of Dimension Capital II.
The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated herein by reference. The percentages set forth in row 13 are based on 47,174,156 shares of Common Stock outstanding, after giving effect to the closing of the Issuer's IPO, as reported by the Issuer in its prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on May 8, 2026.
The information set forth in rows 7 through 10 of the cover pages to this Schedule 13D is incorporated herein by reference.
On May 8, 2026, the closing date of the Issuer's IPO, (i) Dimension Capital II purchased 1,111,111 shares of Common Stock at a purchase price of $18.00 per share and (ii) shares of Preferred Stock held by Dimension Capital II automatically converted into 1,709,543 shares of Common Stock. Except as described herein, none of the Reporting Persons has effected any transaction in Common Stock in the past 60 days.
No person other than the Reporting Persons disclosed in this Schedule 13D is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock subject to this Schedule 13D.
Not applicable.
The information set forth in Item 4 of this Schedule 13D is incorporated herein by reference.
Exhibit 99.1 Joint Filing Agreement